Featured 13F manager
Farallon Capital Management, L.l.c.
San Francisco, CA 87 processed 13Fs on this site · 2021 Q3–2026 Q2
- $21.7B
- 77 Positions
- 2026 Q2
- +23.6% QoQ
- Top 5 29.9%
Portfolio
top 5 29.9% · top 10 44.0%
- RVMD - Revolution Medicines 11.7%
- EA - Electronic Arts 7.5%
- BBIO - Bridgebio Pharma 3.7%
- PTGX - Protagonist Therapeutics 3.6%
- EXEL - Exelixis 3.4%
- LQDA - Liquidia 3.1%
- AMZN - Amazon 2.9%
- LNTH - Lantheus 2.9%
- NTRA - Natera 2.8%
- UNH - Unitedhealth Group 2.4%
- TMO - Thermo Fisher Scientific 2.4%
- ROIV - Roivant Sciences 2.3%
- Other 51.3%
AUM over time
Book
| TMO - Thermo Fisher Scientific | 3.84% | Add +25.8% | 1,223,859 | $590.65 | $723M | +250,900 | +$74M |
| IQV - IQVIA | 3.83% | Add +6.4% | 3,117,582 | $231.21 | $721M | +186,826 | −$106M |
| BSX - Boston Scientific | 3.70% | Reduce −6.4% | 15,740,257 | $44.29 | $697M | −1,074,324 | −$17M |
| TRU - Transunion | 3.40% | Add +121.9% | 6,188,496 | $103.34 | $640M | +3,399,314 | +$309M |
| ARMK - Aramark | 3.29% | Reduce −8.3% | 16,479,798 | $37.60 | $620M | −1,482,685 | −$42M |
| HWM - Howmet Aerospace | 2.60% | Reduce −17.6% | 13,626,353 | $35.94 | $490M | −2,905,100 | −$36M |
| WAB - Wabtec | 2.51% | Reduce −21.4% | 4,907,930 | $96.17 | $472M | −1,333,221 | −$103M |
| GOOG - Alphabet · CL C | 2.49% | Reduce −26.7% | 167,807 | $2,793 | $469M | −61,150 | −$194M |
| META - Meta Platforms · CL A | 2.44% | Add +51.1% | 2,064,740 | $222.36 | $459M | +698,195 | −$521K |
| MSFT - Microsoft | 2.11% | Reduce −5.5% | 1,286,078 | $308.31 | $397M | −75,200 | −$61M |
| MA - Mastercard · CL A | 2.04% | Reduce −3.3% | 1,076,589 | $357.38 | $385M | −36,711 | −$15M |
| ELV - Anthem | 2.01% | Add +1.8% | 768,775 | $491.22 | $378M | +13,715 | +$28M |
| CRM - Salesforce | 1.98% | Add +57.9% | 1,758,338 | $212.32 | $373M | +644,700 | +$90M |
| BX - Blackstone | 1.97% | Add +22.0% | 2,923,451 | $126.94 | $371M | +528,115 | +$61M |
| CNC - Centene Del | 1.81% | Reduce −6.6% | 4,052,344 | $84.19 | $341M | −287,000 | −$16M |
| NYT - New York Times · CL A | 1.79% | Reduce −12.0% | 7,338,354 | $45.84 | $336M | −997,904 | −$66M |
| RTX - Raytheon Technologies | 1.78% | Reduce −41.4% | 3,385,484 | $99.07 | $335M | −2,389,902 | −$162M |
| AON - AON PLC · CL A | 1.75% | Reduce −15.0% | 1,013,986 | $325.63 | $330M | −179,500 | −$29M |
| ADBE - Adobe Systems | 1.71% | Add +87.9% | 706,372 | $455.62 | $322M | +330,372 | +$109M |
| SHW - Sherwin Williams | 1.62% | Add +28.8% | 1,225,092 | $249.62 | $306M | +274,024 | −$29M |
| XYZ - Block · CL A | 1.58% | New | 2,196,000 | $135.60 | $298M | +2,196,000 | +$298M |
| V - VISA · CL A | 1.52% | Reduce −8.7% | 1,291,853 | $221.77 | $286M | −122,751 | −$20M |
| EFX - Equifax | 1.50% | Add +18.7% | 1,192,703 | $237.10 | $283M | +187,520 | −$12M |
| NOW - Servicenow | 1.46% | Reduce −2.1% | 492,350 | $556.89 | $274M | −10,800 | −$52M |
| AVGO - Broadcom | 1.37% | Reduce −15.0% | 408,850 | $629.68 | $257M | −72,150 | −$63M |
| EXEL - Exelixis | 1.27% | Add +18.7% | 10,520,061 | $22.67 | $238M | +1,660,904 | +$77M |
| AZNN — | 1.26% | Add +87.6% | 3,576,184 | $66.34 | $237M | +1,670,029 | +$126M |
| ABBV - Abbvie | 0.99% | Reduce −28.8% | 1,144,667 | $162.11 | $186M | −463,784 | −$32M |
| ALNY - Alnylam Pharmaceuticals | 0.89% | Reduce −14.0% | 1,023,873 | $163.29 | $167M | −166,155 | −$35M |
| YMM - Full Truck Alliance | 0.82% | Add +65.5% | 23,178,743 | $6.67 | $155M | +9,171,000 | +$37M |
| BEAM - Beam Therapeutics | 0.79% | Add +14.5% | 2,594,387 | $57.30 | $149M | +329,342 | −$32M |
| CLVT - Clarivate | 0.78% | New | 8,713,428 | $16.76 | $146M | +8,713,428 | +$146M |
| AVTR - Avantor | 0.68% | Add +4.5% | 3,807,112 | $33.82 | $129M | +164,254 | −$25M |
| Lufax · CL A | 0.65% | Add +15.9% | 22,034,399 | $5.57 | $123M | +3,015,000 | +$16M |
| CVS - Cvs Health | 0.64% | Reduce −7.4% | 1,186,283 | $101.21 | $120M | −95,173 | −$12M |
| Laboratory Amer | 0.60% | Add +3.8% | 430,014 | $263.66 | $113M | +15,845 | −$17M |
| ENTA - Enanta Pharmaceuticals | 0.59% | Reduce −1.5% | 1,550,000 | $71.18 | $110M | −23,829 | −$7M |
| BEKE - KE | 0.57% | Add +523.7% | 8,713,500 | $12.37 | $108M | +7,316,500 | +$80M |
| TSM - Taiwan Semiconductor Mfg | 0.57% | New | 1,028,125 | $104.26 | $107M | +1,028,125 | +$107M |
| IOVA - Iovance Biotherapeutics | 0.55% | Add +1.9% | 6,175,357 | $16.65 | $103M | +113,384 | −$13M |
| Blueprint Medicines | 0.46% | Add +67.2% | 1,356,987 | $63.88 | $87M | +545,240 | −$262K |
| RVMD - Revolution Medicines | 0.44% | Add +18.2% | 3,250,000 | $25.51 | $83M | +500,000 | +$14M |
| Catalent | 0.42% | Reduce −6.2% | 716,555 | $110.90 | $79M | −47,006 | −$18M |
| Sarepta Therapeutics | 0.41% | Add +18.2% | 991,975 | $78.12 | $77M | +152,966 | +$2M |
| Zendesk | 0.40% | Add +46.5% | 630,000 | $120.29 | $76M | +200,000 | +$31M |
| PCG - Pg And E | 0.40% | Hold | 6,305,142 | $11.94 | $75M | — | — |
| Amyris | 0.39% | Add +55.9% | 16,931,427 | $4.36 | $74M | +6,071,616 | +$15M |
| INSP - Inspire Med Sys | 0.39% | New | 283,500 | $256.69 | $73M | +283,500 | +$73M |
| CYTK - Cytokinetics | 0.37% | Reduce −13.3% | 1,882,599 | $36.81 | $69M | −287,743 | −$30M |
| BRKR - Bruker | 0.36% | Add +42.5% | 1,061,800 | $64.30 | $68M | +316,534 | +$6M |
| UTHR - United Therapeutics | 0.36% | Add +18.4% | 379,696 | $179.41 | $68M | +58,936 | −$1M |
| Atento S A | 0.33% | Hold | 2,230,357 | $27.65 | $62M | — | — |
| Exact Sciences | 0.30% | Add +149.4% | 802,898 | $69.92 | $56M | +481,000 | +$31M |
| JAZZ - Jazz Pharmaceuticals | 0.27% | Reduce −23.7% | 329,000 | $155.67 | $51M | −102,021 | −$4M |
| Imago Biosciences | 0.25% | Hold | 2,471,313 | $19.27 | $48M | — | — |
| NTRA - Natera | 0.24% | Reduce −25.2% | 1,101,252 | $40.68 | $45M | −371,463 | −$93M |
| Karuna Therapeutics | 0.24% | Reduce −36.4% | 350,000 | $126.79 | $44M | −200,000 | −$28M |
| DIDIY - Didi Global | 0.22% | New | 16,868,328 | $2.50 | $42M | +16,868,328 | +$42M |
| Broadmark Rlty Cap | 0.22% | Hold | 4,850,000 | $8.65 | $42M | — | — |
| RGEN - Repligen | 0.22% | Add +63.7% | 222,979 | $188.09 | $42M | +86,734 | +$6M |
| BIIB - Biogen | 0.22% | Add +33.9% | 197,799 | $210.60 | $42M | +50,090 | +$6M |
| AGIO - Agios Pharmaceuticals | 0.21% | Add +6.1% | 1,333,012 | $29.11 | $39M | +76,434 | −$2M |
| Mantech International · CL A | 0.17% | New | 375,000 | $86.19 | $32M | +375,000 | +$32M |
| Cara Therapeutics | 0.16% | Add +25.0% | 2,500,000 | $12.15 | $30M | +500,000 | +$6M |
| Marblegate Acquisition · CL A | 0.16% | Hold | 2,970,000 | $9.85 | $29M | — | — |
| GPOR - Gulfport Energy | 0.15% | Add +5.2% | 311,845 | $89.82 | $28M | +15,473 | +$7M |
| Holding · CL A | 0.15% | Hold | 2,809,000 | $9.77 | $27M | — | — |
| PTGX - Protagonist Therapeutics | 0.14% | Reduce −40.8% | 1,134,457 | $23.68 | $27M | −782,677 | −$39M |
| Holding · CL A | 0.14% | Add +35.1% | 1,350,500 | $19.89 | $27M | +350,500 | +$7M |
| Generation Bio | 0.14% | Hold | 3,500,000 | $7.34 | $26M | — | — |
| Metals Acquisition · CL A | 0.13% | Add +0.6% | 2,489,700 | $9.96 | $25M | +14,700 | +$901K |
| Holding · CL A | 0.13% | Hold | 2,500,000 | $9.82 | $25M | — | — |
| CRBU - Caribou Biosciences | 0.13% | Reduce −10.3% | 2,657,052 | $9.18 | $24M | −306,396 | −$20M |
| Berenson Acquisition I · CL A | 0.13% | Hold | 2,475,000 | $9.75 | $24M | — | — |
| Revolution Healthcar Aq · CLASS A | 0.10% | Hold | 2,000,000 | $9.81 | $20M | — | — |
| Swiftmerge Acquisition · CLASS A | 0.10% | New | 1,980,000 | $9.82 | $19M | +1,980,000 | +$19M |
| Radius Health | 0.10% | Hold | 2,107,400 | $8.83 | $19M | — | — |
| Holding · CLASS A | 0.10% | Hold | 1,900,000 | $9.67 | $18M | — | — |
| Cdk Global | 0.10% | New | 370,000 | $48.68 | $18M | +370,000 | +$18M |
| Fortress Value Acquisi · CL A | 0.09% | Hold | 1,750,000 | $9.80 | $17M | — | — |
| Holding · CLASS A | 0.09% | Hold | 1,732,500 | $9.82 | $17M | — | — |
| Sdcl Edge Acquisition · CL A | 0.09% | Hold | 1,732,500 | $9.76 | $17M | — | — |
| Vector Acquisition Ii · CL A | 0.09% | Hold | 1,700,000 | $9.75 | $17M | — | — |
| Shelter Acquisition I · CLASS A | 0.09% | Hold | 1,650,000 | $9.80 | $16M | — | — |
| QTRX - Quanterix | 0.08% | Hold | 545,000 | $29.19 | $16M | — | — |
| VEON - Veoneer | 0.08% | New | 427,500 | $36.95 | $16M | +427,500 | +$16M |
| NUVB - Nuvation Bio · CL A | 0.08% | Add +102.8% | 2,900,000 | $5.26 | $15M | +1,470,000 | +$3M |
| Ventyx Biosciences | 0.08% | Hold | 1,114,280 | $13.57 | $15M | — | — |
| Big Sky Growth Partners · CLASS A | 0.08% | Hold | 1,550,000 | $9.73 | $15M | — | — |
| PACB — | 0.08% | Reduce −20.2% | 1,631,800 | $9.10 | $15M | −413,688 | −$27M |
| KKR - Kkr Acquisition I · CLASS A | 0.08% | Hold | 1,500,000 | $9.83 | $15M | — | — |
| Holding · CL A | 0.08% | Hold | 1,500,000 | $9.78 | $15M | — | — |
| Ares Acquisition · CL A | 0.07% | Hold | 1,425,000 | $9.81 | $14M | — | — |
| Humanco Acquisition · CL A | 0.07% | Hold | 1,407,749 | $9.81 | $14M | — | — |
| Disruptive Acquisition · CLASS A | 0.07% | Hold | 1,400,000 | $9.78 | $14M | — | — |
| Holding · CLASS A | 0.07% | Hold | 1,360,040 | $9.71 | $13M | — | — |
| Forest Road Acquisition Cor · CL A | 0.06% | Hold | 1,250,000 | $9.77 | $12M | — | — |
| Holding · CL A | 0.06% | Hold | 1,208,326 | $9.82 | $12M | — | — |
| Tcv Acquisition · CL A | 0.06% | Hold | 1,211,459 | $9.76 | $12M | — | — |
| Nightdragon Acquisition · CLASS A | 0.06% | Hold | 1,200,000 | $9.77 | $12M | — | — |
| Agile Growth · CLASS A | 0.06% | Hold | 1,200,000 | $9.75 | $12M | — | — |
| Gores Vii · CL A | 0.06% | Hold | 1,150,162 | $9.79 | $11M | — | — |
| Savara | 0.06% | Add +9.5% | 8,505,403 | $1.31 | $11M | +735,141 | +$2M |
| Tiga Acquisition · CL A | 0.06% | Hold | 1,080,000 | $10.25 | $11M | — | — |
| Holding · CL A | 0.06% | Hold | 1,120,102 | $9.83 | $11M | — | — |
| Tpg Pace Beneficial Ii | 0.06% | Hold | 1,116,833 | $9.82 | $11M | — | — |
| Concord Acquisition · CL A | 0.05% | New | 1,005,100 | $9.95 | $10M | +1,005,100 | +$10M |
| Cascade Acquisition · CL A | 0.05% | Hold | 990,000 | $10.08 | $10M | — | — |
| Holding · CL A | 0.05% | Hold | 1,000,000 | $9.86 | $10M | — | — |
| Churchill Capital Vii · CL A | 0.05% | Hold | 1,000,000 | $9.79 | $10M | — | — |
| Holding · CLASS A | 0.05% | Add +31.4% | 985,300 | $9.92 | $10M | +235,300 | +$2M |
| Holding · CLASS A | 0.05% | Hold | 1,000,000 | $9.77 | $10M | — | — |
| Forum Merger Iv · CLASS A | 0.05% | Hold | 1,000,000 | $9.77 | $10M | — | — |
| Screaming Eagle Acquisitn · CLASS A | 0.05% | New | 1,000,000 | $9.73 | $10M | +1,000,000 | +$10M |
| Peoples United Financial | 0.05% | New | 485,000 | $19.99 | $10M | +485,000 | +$10M |
| Holding · CL A | 0.05% | New | 900,000 | $10.00 | $9M | +900,000 | +$9M |
| Interprivate Ii Acquisition · CL A | 0.05% | Hold | 882,647 | $9.77 | $9M | — | — |
| Rxr Acquisition · CLASS A | 0.04% | Hold | 854,961 | $9.75 | $8M | — | — |
| Holding | 0.04% | Hold | 848,184 | $9.78 | $8M | — | — |
| Holding · CLASS A | 0.04% | Hold | 843,046 | $9.78 | $8M | — | — |
| Holding · CLASS A | 0.04% | Hold | 835,638 | $9.73 | $8M | — | — |
| Ready Capital | 0.04% | Reduce −50.5% | 534,900 | $15.06 | $8M | −546,061 | −$9M |
| Landcadia Iv · CLASS A | 0.04% | Hold | 802,028 | $9.82 | $8M | — | — |
| Holding · CL A | 0.04% | Hold | 800,000 | $9.81 | $8M | — | — |
| Arya Sciences Acqu Iv · CL A | 0.04% | Hold | 800,000 | $9.79 | $8M | — | — |
| Levere · CLASS A | 0.04% | Hold | 800,000 | $9.78 | $8M | — | — |
| Zealand Pharma A/S | 0.04% | Reduce −2.6% | 496,890 | $15.59 | $8M | −13,110 | −$3M |
| Holding · CL A | 0.04% | Hold | 775,200 | $9.93 | $8M | — | — |
| Churchill Capital Vi · CL A | 0.04% | Hold | 782,767 | $9.82 | $8M | — | — |
| Holding · CLASS A | 0.04% | New | 750,000 | $9.93 | $7M | +750,000 | +$7M |
| Holding · CL A | 0.04% | Hold | 750,000 | $9.82 | $7M | — | — |
| Holding · CL A | 0.04% | Hold | 750,000 | $9.80 | $7M | — | — |
| Social Leverage Acquisn · CL A | 0.04% | Hold | 750,000 | $9.79 | $7M | — | — |
| Panacea Acquisition Ii · CL A | 0.04% | Hold | 750,000 | $9.78 | $7M | — | — |
| Pathfinder Acquisition · CL A | 0.04% | Hold | 750,000 | $9.78 | $7M | — | — |
| Research Alliance Ii · CL A | 0.04% | Hold | 750,000 | $9.76 | $7M | — | — |
| Holding · CLASS A | 0.04% | Hold | 745,000 | $9.72 | $7M | — | — |
| Gores Viii · CL A | 0.04% | Hold | 692,810 | $9.95 | $7M | — | — |
| Khosla Ventures Acquisition · CL A | 0.04% | Hold | 700,000 | $9.78 | $7M | — | — |
| Holding · CL A | 0.04% | Hold | 700,000 | $9.78 | $7M | — | — |
| Corsair Partnering · CL A | 0.04% | Hold | 700,000 | $9.71 | $7M | — | — |
| RCEL - Avita Medical | 0.04% | Hold | 800,000 | $8.48 | $7M | — | — |
| ARWR - Arrowhead Pharmaceuticals | 0.03% | Reduce −55.5% | 142,700 | $45.99 | $7M | −177,917 | −$15M |
| COGT - Cogent Biosciences | 0.03% | Add +41.7% | 850,000 | $7.49 | $6M | +250,000 | +$1M |
| Rocket Internet Grwt Oprt · CL A | 0.03% | Hold | 647,945 | $9.79 | $6M | — | — |
| Clever Leaves | 0.03% | Reduce −20.1% | 2,436,431 | $2.49 | $6M | −613,422 | −$3M |
| Theseus Pharmaceuticals | 0.03% | Hold | 523,979 | $11.53 | $6M | — | — |
| Rcf Acquisition · CL A | 0.03% | New | 600,000 | $9.94 | $6M | +600,000 | +$6M |
| Holding | 0.03% | Add +96.0% | 169,458 | $34.64 | $6M | +83,004 | +$3M |
| Finserv Acquisition Ii · CL A | 0.03% | Hold | 600,000 | $9.76 | $6M | — | — |
| Holding · CLASS A | 0.03% | Hold | 600,000 | $9.75 | $6M | — | — |
| Blue Whale Acquisition · CLASS A | 0.03% | Hold | 575,000 | $9.70 | $6M | — | — |
| SLAM · CL A | 0.03% | Hold | 570,396 | $9.77 | $6M | — | — |
| Point Biopharma Global | 0.03% | Reduce −63.3% | 626,322 | $7.97 | $5M | −1,080,007 | −$5M |
| G Squared Ascend I · CL A | 0.03% | Hold | 500,000 | $9.85 | $5M | — | — |
| Tio Tech A · CLASS A | 0.03% | Hold | 502,001 | $9.79 | $5M | — | — |
| Ftac Hera Acquisition · CLASS A | 0.03% | Hold | 500,000 | $9.79 | $5M | — | — |
| Gores Ix · CLASS A | 0.03% | New | 500,000 | $9.78 | $5M | +500,000 | +$5M |
| Holding · CL A | 0.03% | Hold | 500,000 | $9.77 | $5M | — | — |
| Ikena Oncology | 0.03% | Reduce −26.7% | 792,077 | $6.10 | $5M | −289,232 | −$9M |
| Holding · CL A | 0.03% | Hold | 484,709 | $9.76 | $5M | — | — |
| Holding · CLASS A | 0.02% | Hold | 452,519 | $9.80 | $4M | — | — |
| Scion Tech Growth Ii · CL A | 0.02% | Hold | 450,000 | $9.80 | $4M | — | — |
| Fibrogen | 0.02% | Reduce −60.3% | 364,764 | $12.02 | $4M | −554,353 | −$9M |
| Holding | 0.02% | Hold | 810,500 | $5.34 | $4M | — | — |
| Ldh Growth I · CLASS A | 0.02% | Hold | 436,702 | $9.78 | $4M | — | — |
| Svf Investment · CL A | 0.02% | Hold | 425,000 | $9.80 | $4M | — | — |
| Vpc Impact Acquisition · CLASS A | 0.02% | Hold | 425,000 | $9.80 | $4M | — | — |
| Lamf Global Ventures I · CLASS A | 0.02% | New | 400,000 | $9.94 | $4M | +400,000 | +$4M |
| Holding · CL A | 0.02% | Hold | 400,000 | $9.88 | $4M | — | — |
| Holding · CLASS A | 0.02% | Hold | 400,000 | $9.75 | $4M | — | — |
| Cartica Acquisition · CLASS A | 0.02% | New | 350,000 | $9.99 | $3M | +350,000 | +$3M |
| Holding · CLASS A | 0.02% | New | 350,000 | $9.91 | $3M | +350,000 | +$3M |
| Uta Acquisition · CLASS A | 0.02% | New | 350,000 | $9.85 | $3M | +350,000 | +$3M |
| Sound Point Acquisition | 0.02% | New | 300,000 | $10.06 | $3M | +300,000 | +$3M |
| Holding · CLASS A | 0.02% | New | 300,000 | $9.93 | $3M | +300,000 | +$3M |
| Holding · CL A | 0.02% | Hold | 304,698 | $9.76 | $3M | — | — |
| Lazard Growth Acquisition · CL A | 0.02% | Hold | 300,000 | $9.80 | $3M | — | — |
| Ferro | 0.01% | New | 114,963 | $21.74 | $2M | +114,963 | +$2M |
| Broadscale Acquisition · CL A | 0.01% | Hold | 250,000 | $9.83 | $2M | — | — |
| Live Oak Mobility Acquisi · CL A | 0.01% | Hold | 250,000 | $9.81 | $2M | — | — |
| Hudson Executive Inves Iii · CL A | 0.01% | Hold | 250,000 | $9.77 | $2M | — | — |
| TNGX - Tango Therapeutics | 0.01% | Hold | 300,000 | $7.58 | $2M | — | — |
| Better Therapeutics | 0.01% | Reduce −15.0% | 1,147,400 | $1.98 | $2M | −202,600 | −$4M |
| Arctos Northstar Acquis · CL A | 0.01% | Hold | 200,000 | $9.79 | $2M | — | — |
| Priveterra Acquisition · CL A | 0.01% | Hold | 150,000 | $9.78 | $1M | — | — |
| FATE - Fate Therapeutics | 0.01% | Reduce −95.8% | 31,900 | $38.78 | $1M | −725,525 | −$43M |
| The Music Acquisition · CLASS A | 0.01% | Hold | 125,000 | $9.75 | $1M | — | — |
| Liberty Media Acquisition | 0.01% | New | 115,658 | $9.91 | $1M | +115,658 | +$1M |
| Holding | 0.01% | New | 100,000 | $10.07 | $1M | +100,000 | +$1M |
| Crypto 1 Acquisition · CLASS A | 0.01% | New | 100,000 | $9.90 | $990K | +100,000 | +$990K |
| NTRS - Northern Trust · CL A | 0.01% | Hold | 100,000 | $9.79 | $979K | — | — |
| Avrobio | 0.01% | Hold | 740,000 | $1.32 | $977K | — | — |
| NTRS - Northern Trust · CL A | 0.01% | Hold | 100,000 | $9.76 | $976K | — | — |
| OKLO - Altc Acquisition · CL A | 0.01% | Hold | 98,300 | $9.76 | $959K | — | — |
| VCYT - Veracyte | 0.00% | Reduce −83.0% | 32,500 | $27.57 | $896K | −158,658 | −$7M |
| CMPX - Compass Therapeutics | 0.00% | Reduce −41.7% | 582,750 | $1.37 | $798K | −417,250 | −$2M |
| Dariohealth | 0.00% | Reduce −75.4% | 133,083 | $5.84 | $777K | −406,917 | −$6M |
| ANNX - Annexon | 0.00% | Reduce −44.1% | 255,705 | $2.73 | $698K | −202,059 | −$5M |
| Holding | 0.00% | Hold | 85,838 | $7.20 | $618K | — | — |
| Ion Acquisition 3 · CL A | 0.00% | Hold | 56,151 | $9.76 | $548K | — | — |
| Holding | 0.00% | Hold | 130,000 | $1.15 | $150K | — | — |
Showing top 50 of 202 by value
Exits / last held
not current holdings · last reported size, unchanged · gone vs 2021 Q4
| Stock | % of portfolio | Recent activity | Shares | Reported price* | Value | Share change | $ change |
|---|---|---|---|---|---|---|---|
| BHP Group | 2.16% | Exit | 0 | $59.77 | $406M | −6,785,000 | −$406M |
| CHTR - Charter Communications · CL A | 1.10% | Exit | 0 | $651.97 | $206M | −315,701 | −$206M |
| Horizon Therapeutics Pub L | 0.80% | Exit | 0 | $107.76 | $150M | −1,396,217 | −$150M |
| Qiagen | 0.24% | Exit | 0 | $55.58 | $45M | −814,064 | −$45M |
| Zogenix | 0.24% | Exit | 0 | $16.25 | $45M | −2,766,935 | −$45M |
| Chemocentryx | 0.18% | Exit | 0 | $36.41 | $34M | −935,463 | −$34M |
| Somalogic · CLASS A | 0.11% | Exit | 0 | $11.64 | $21M | −1,808,907 | −$21M |
| Swiftmerge Acquisition | 0.11% | Exit | 0 | $9.94 | $20M | −1,980,000 | −$20M |
| Berkeley Lts | 0.08% | Exit | 0 | $18.18 | $14M | −787,327 | −$14M |
| Gores Metropoulos Ii · CL A | 0.06% | Exit | 0 | $9.97 | $11M | −1,100,000 | −$11M |
| Holding · CL A | 0.05% | Exit | 0 | $9.89 | $10M | −1,000,000 | −$10M |
| Holding | 0.05% | Exit | 0 | $10.15 | $9M | −900,000 | −$9M |
| Exscientia | 0.04% | Exit | 0 | $19.76 | $8M | −425,000 | −$8M |
| Holding · CL A | 0.04% | Exit | 0 | $9.90 | $8M | −825,100 | −$8M |
| Holding | 0.04% | Exit | 0 | $10.03 | $8M | −750,000 | −$8M |
| Holding · CL A | 0.03% | Exit | 0 | $10.25 | $6M | −600,000 | −$6M |
| Rcf Acquisition | 0.03% | Exit | 0 | $10.10 | $6M | −600,000 | −$6M |
| Lamf Global Ventures I | 0.02% | Exit | 0 | $10.04 | $4M | −400,000 | −$4M |
| Lianbio | 0.02% | Exit | 0 | $6.16 | $4M | −600,000 | −$4M |
| Holding | 0.02% | Exit | 0 | $10.15 | $4M | −350,000 | −$4M |
| Uta Acquisition | 0.02% | Exit | 0 | $10.05 | $4M | −350,000 | −$4M |
| Holding | 0.02% | Exit | 0 | $10.11 | $3M | −300,000 | −$3M |
| Surface Oncology | 0.01% | Exit | 0 | $4.78 | $2M | −520,021 | −$2M |
| Holding · CL A | 0.01% | Exit | 0 | $10.29 | $2M | −177,580 | −$2M |
| Crypto 1 Acquisition | 0.01% | Exit | 0 | $10.10 | $1M | −100,000 | −$1M |
| GRFS - Grifols S A | — | Exit | 0 | $11.22 | $596K | −53,133 | −$596K |
| Holding · CL A | — | Exit | 0 | $9.87 | $593K | −60,053 | −$593K |
Filings history
20 periods · normalized AUM · open a period for holdings
| Period | Holdings | AUM | QoQ | Form | Filed | Filing ID |
|---|---|---|---|---|---|---|
| 2026 Q2 | 89 | $21.7B | +23.6% | 13F-HR | 8/14/2026 | 000090883426000432 |
| 2026 Q1 | 1 | $1.5B | — | new holds | 8/14/2026 | 000090883426000434 |
| 2026 Q1 | 172 | $17.5B | −17.2% | 13F-HR | 5/15/2026 | 000090883426000240 |
| 2025 Q4 | 1 | $1B | — | new holds | 8/14/2026 | 000090883426000433 |
| 2025 Q4 | 2 | $884M | — | new holds | 5/15/2026 | 000090883426000241 |
| 2025 Q4 | 151 | $21.2B | −13.2% | 13F-HR | 2/17/2026 | 000090883426000087 |
| 2025 Q3 | 144 | $24.4B | — | RESTATEMENT | 2/17/2026 | 000090883426000086 |
| 2025 Q3 | 144 | $24.4B | +5.4% | 13F-HR | 11/14/2025 | 000090883425000353 |
| 2025 Q2 | 1 | $140M | — | new holds | 2/17/2026 | 000090883426000085 |
| 2025 Q2 | 3 | $483M | — | new holds | 11/14/2025 | 000090883425000352 |
| 2025 Q2 | 141 | $23.2B | +29.2% | 13F-HR | 8/14/2025 | 000090883425000248 |
| 2025 Q1 | 1 | $274M | — | new holds | 2/17/2026 | 000090883426000084 |
| 2025 Q1 | 3 | $416M | — | new holds | 11/14/2025 | 000090883425000351 |
| 2025 Q1 | 7 | $2.2B | — | new holds | 8/14/2025 | 000090883425000247 |
| 2025 Q1 | 135 | $17.9B | −9.0% | 13F-HR | 5/15/2025 | 000090883425000177 |
| 2024 Q4 | 1 | $85M | — | new holds | 2/17/2026 | 000090883426000083 |
| 2024 Q4 | 2 | $349M | — | new holds | 11/14/2025 | 000090883425000350 |
| 2024 Q4 | 6 | $2.3B | — | new holds | 8/14/2025 | 000090883425000246 |
| 2024 Q4 | 4 | $333M | — | new holds | 5/15/2025 | 000090883425000180 |
| 2024 Q4 | 138 | $19.7B | −3.5% | 13F-HR | 2/14/2025 | 000090883425000081 |
| 2024 Q3 | 1 | $145M | — | new holds | 11/14/2025 | 000090883425000349 |
| 2024 Q3 | 6 | $1.5B | — | new holds | 8/14/2025 | 000090883425000243 |
| 2024 Q3 | 3 | $216M | — | new holds | 5/15/2025 | 000090883425000179 |
| 2024 Q3 | 2 | $544M | — | new holds | 2/14/2025 | 000090883425000080 |
| 2024 Q3 | 153 | $20.4B | −3.6% | 13F-HR | 11/14/2024 | 000090883424000307 |
| 2024 Q2 | 1 | $120M | — | new holds | 11/14/2025 | 000090883425000348 |
| 2024 Q2 | 5 | $1.2B | — | new holds | 8/14/2025 | 000090883425000245 |
| 2024 Q2 | 1 | $199M | — | new holds | 5/15/2025 | 000090883425000178 |
| 2024 Q2 | 2 | $452M | — | new holds | 2/14/2025 | 000090883425000079 |
| 2024 Q2 | 1 | $149M | — | new holds | 11/14/2024 | 000090883424000324 |
| 2024 Q2 | 157 | $21.2B | −4.2% | 13F-HR | 8/14/2024 | 000090883424000200 |
| 2024 Q1 | 1 | $93M | — | new holds | 11/14/2025 | 000090883425000347 |
| 2024 Q1 | 4 | $1.2B | — | new holds | 8/14/2025 | 000090883425000244 |
| 2024 Q1 | 2 | $159M | — | new holds | 2/14/2025 | 000090883425000078 |
| 2024 Q1 | 1 | $45M | — | new holds | 8/14/2024 | 000090883424000202 |
| 2024 Q1 | 167 | $22.1B | — | RESTATEMENT | 5/24/2024 | 000090883424000159 |
| 2024 Q1 | 167 | $22.1B | +9.8% | 13F-HR | 5/15/2024 | 000090883424000135 |
| 2023 Q4 | 1 | $65M | — | new holds | 11/14/2025 | 000090883425000346 |
| 2023 Q4 | 2 | $548M | — | new holds | 8/14/2025 | 000090883425000250 |
| 2023 Q4 | 5 | $1.1B | — | new holds | 5/15/2024 | 000090883424000141 |
| 2023 Q4 | 150 | $20.1B | +1.0% | 13F-HR | 2/14/2024 | 000090883424000070 |
| 2023 Q3 | 1 | $40M | — | new holds | 11/14/2025 | 000090883425000345 |
| 2023 Q3 | 1 | $40M | — | new holds | 5/15/2024 | 000090883424000138 |
| 2023 Q3 | 2 | $1.4B | — | new holds | 2/14/2024 | 000090883424000077 |
| 2023 Q3 | 1 | $1.9B | — | new holds | 2/12/2024 | 000090883424000049 |
| 2023 Q3 | 159 | $20B | +11.5% | 13F-HR | 11/14/2023 | 000090883423000150 |
| 2023 Q2 | 2 | $669M | — | new holds | 2/14/2024 | 000090883424000076 |
| 2023 Q2 | 5 | $1.4B | — | new holds | 11/14/2023 | 000090883423000157 |
| 2023 Q2 | 1 | $1.2B | — | new holds | 10/26/2023 | 000090883423000134 |
| 2023 Q2 | 165 | $17.9B | +1.3% | 13F-HR | 8/14/2023 | 000090883423000109 |
| 2023 Q1 | 2 | $234M | — | new holds | 2/14/2024 | 000090883424000075 |
| 2023 Q1 | 3 | $389M | — | new holds | 11/14/2023 | 000090883423000156 |
| 2023 Q1 | 1 | $15M | — | new holds | 8/14/2023 | 000090883423000110 |
| 2023 Q1 | 187 | $17.7B | +15.8% | 13F-HR | 5/15/2023 | 000117570723000127 |
| 2022 Q4 | 1 | $171M | — | new holds | 2/14/2024 | 000090883424000074 |
| 2022 Q4 | 3 | $485M | — | new holds | 11/14/2023 | 000090883423000155 |
| 2022 Q4 | 7 | $1B | — | new holds | 5/15/2023 | 000117570723000136 |
| 2022 Q4 | 232 | $15.3B | −9.3% | 13F-HR | 2/14/2023 | 000117570723000051 |
| 2022 Q3 | 1 | $125M | — | new holds | 2/14/2024 | 000090883424000073 |
| 2022 Q3 | 3 | $415M | — | new holds | 11/14/2023 | 000090883423000154 |
| 2022 Q3 | 5 | $411M | — | new holds | 5/15/2023 | 000117570723000135 |
| 2022 Q3 | 4 | $434M | — | new holds | 2/14/2023 | 000090966123000005 |
| 2022 Q3 | 298 | $16.8B | +3.5% | 13F-HR | 11/14/2022 | 000156761922019851 |
| 2022 Q2 | 1 | $115M | — | new holds | 2/14/2024 | 000090883424000081 |
| 2022 Q2 | 3 | $411M | — | new holds | 11/14/2023 | 000090883423000153 |
| 2022 Q2 | 2 | $337M | — | new holds | 5/15/2023 | 000117570723000134 |
| 2022 Q2 | 3 | $136M | — | new holds | 2/14/2023 | 000090966123000003 |
| 2022 Q2 | 9 | $1.2B | — | new holds | 11/14/2022 | 000156761922019862 |
| 2022 Q2 | 297 | $16.3B | −13.7% | 13F-HR | 8/15/2022 | 000156761922015953 |
| 2022 Q1 | 1 | $268M | — | new holds | 11/14/2023 | 000090883423000152 |
| 2022 Q1 | 1 | $314M | — | new holds | 5/15/2023 | 000117570723000133 |
| 2022 Q1 | 1 | $27M | — | new holds | 2/14/2023 | 000090966123000002 |
| 2022 Q1 | 3 | $186M | — | new holds | 11/14/2022 | 000156761922019864 |
| 2022 Q1 | 8 | $1.1B | — | new holds | 8/15/2022 | 000156761922015972 |
| 2022 Q1 | 307 | $18.8B | +0.4% | 13F-HR | 5/16/2022 | 000156761922010736 |
| 2021 Q4 | 1 | $227M | — | new holds | 5/15/2023 | 000117570723000132 |
| 2021 Q4 | 1 | $7M | — | new holds | 11/14/2022 | 000156761922019852 |
| 2021 Q4 | 1 | $115M | — | new holds | 8/15/2022 | 000156761922015968 |
| 2021 Q4 | 2 | $98M | — | new holds | 5/19/2022 | 000156761922011257 |
| 2021 Q4 | 6 | $833M | — | new holds | 5/16/2022 | 000156761922010757 |
| 2021 Q4 | 289 | $18.7B | −5.1% | 13F-HR | 2/14/2022 | 000156761922003965 |
| 2021 Q3 | 1 | $182M | — | new holds | 5/15/2023 | 000117570723000131 |
| 2021 Q3 | 1 | $105M | — | new holds | 8/15/2022 | 000156761922015964 |
| 2021 Q3 | 1 | $57M | — | new holds | 5/19/2022 | 000156761922011256 |
| 2021 Q3 | 3 | $998M | — | new holds | 5/16/2022 | 000156761922010753 |
| 2021 Q3 | 2 | $344M | — | new holds | 2/14/2022 | 000156761922003981 |
| 2021 Q3 | 293 | $19.7B | — | 13F-HR | 11/15/2021 | 000095012321015168 |
About
FARALLON CAPITAL MANAGEMENT, L.L.C.
87 processed 13Fs on this site · 2021 Q3–2026 Q2